Related Experiment Video
Updated: Jul 15, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Culprit only versus complete coronary revascularization during primary PCI
Dahud Qarawani1, Menachem Nahir, Mouin Abboud
1Cardiovascular Department, Poria Medical Center, Israel.
International Journal of Cardiology
|April 13, 2007
Summary
Complete revascularization during primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is safe and improves clinical outcomes. This approach reduces major cardiac events and shortens hospital stays compared to treating only the culprit artery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Background:
- Primary percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI), typically targeting only the culprit artery.
- Limited data exist on simultaneous non-culprit vessel PCI during the primary procedure.
- This study investigates the safety and efficacy of complete revascularization in STEMI patients.
Purpose of the Study:
- To evaluate the hypothesis that complete revascularization during primary PCI for STEMI is safe.
- To assess if complete revascularization improves clinical outcomes during the indexed hospitalization.
- To compare complete revascularization (CR) versus culprit-only revascularization (COR) in STEMI patients.
Main Methods:
- A prospective study of 120 consecutive STEMI patients with multivessel coronary stenosis.
- Ninety-five patients underwent complete revascularization (CR), treating both culprit and significant non-culprit lesions.
- Twenty-five patients underwent culprit-only revascularization (COR), leaving non-culprit lesions untreated during primary PCI.
Main Results:
- Complete revascularization (CR) significantly reduced major adverse cardiac events (16.7% vs. 52%, P=0.0001), including recurrent ischemia, reinfarction, acute heart failure, and in-hospital mortality.
- CR group showed lower rates of recurrent ischemia (4.2% vs. 32%), reinfarction (3.1% vs. 16%), reintervention (7.3% vs. 32%), and acute heart failure (9.4% vs. 32%).
- Hospitalization was shorter in the CR group (4.4 vs. 9.6 days, P=0.001), though transient renal dysfunction was more frequent (8.4% vs. 4%). In-hospital and one-year mortality were similar.
Conclusions:
- Multivessel PCI during acute myocardial infarction is feasible and safe.
- Complete revascularization during primary PCI for STEMI leads to an improved acute clinical course.
- These findings support a strategy of complete revascularization in STEMI patients undergoing primary PCI.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...